Professional medical organizations, such as the American Medical Association (AMA), American Hospital Association (AHA), and American College of Physicians (ACP), do more than set policy. They are custodians of medicine’s ethical core, defenders of science, and guardians of public trust. Yet, at critical moments, these organizations too often fall back on a strategy of silence. That silence is not neutral. It carries real consequences.
Mixed messages, missed voices
Consider a recent example. In September 2025, the FDA revised labeling for acetaminophen, warning of a possible link between prenatal use and neurodevelopmental conditions like autism and ADHD. The agency carefully noted that the evidence is inconclusive, and that acetaminophen remains the safer choice for pain and fever in pregnancy. On the same day, the World Health Organization issued its own statement: no conclusive evidence supports a causal link. Meanwhile, the American College of Obstetricians and Gynecologists reiterated that acetaminophen remains appropriate when used at the lowest effective dose. Patients and clinicians were left in a fog of competing messages, desperate for clarity. Who should they trust? And where was the unified, visible leadership from America’s professional organizations?
Why the silence
Leaders in medicine often defend their quiet stance as diplomacy. They argue that real advocacy happens behind closed doors, where relationships can be preserved and negotiations kept civil. Yet beneath that explanation lie deeper pressures. Financial dependence on government reimbursement makes open confrontation risky; no one wants to bite the hand that regulates and pays. Fear of partisanship further muzzles organizations, whose leaders worry about alienating members on either side of the political divide. And then there is the weight of bureaucracy: endless committees and slow institutional processes that delay action even when quick, clear voices are most needed. These realities may explain why silence persists, but they cannot excuse it. In moments of crisis, muted responses are indistinguishable from complicity.
Silence in medicine is never neutral. What may seem like cautious restraint quickly becomes complicity. When professional organizations stay quiet while evidence-based medicine is undermined, their silence looks like tacit endorsement. The fallout is far-reaching. Public trust erodes as misinformation fills the vacuum left by absent voices. Within the profession, clinicians and trainees begin to feel abandoned, wondering whether their representative bodies truly represent them. Globally, America’s standing in health leadership weakens, for credibility depends on a visible defense of scientific integrity. Most devastating of all, silence leaves patients, especially the most vulnerable, without protection. When evidence-based care is restricted or confused, patients will be the ones who pay the price for organizational hesitation.
Finding medicine’s voice again
If medical organizations want to restore credibility and fulfill their ethical obligations, they must rediscover their public voice. That means:
- Coordinated statements: Multiple associations speaking together amplify influence and ensure clarity. Fragmented responses only confuse.
- Transparent reasoning: When organizations choose restraint, they must explain why. Otherwise, members interpret silence as abandonment.
- Elevating frontline voices: Practicing clinicians should help shape advocacy, breaking through bureaucratic inertia and ensuring urgency.
- Direct community engagement: Speaking not only to policymakers but also to the public can counter misinformation and rebuild trust.
Neutrality should not mean disengagement. It should mean nonpartisan advocacy rooted in medicine’s ethical duty: defending patients and defending science. There are promising signs. Recently, the AMA adopted policies specifically aimed at combating health disinformation. Collaborative advocacy across specialties is growing. These steps hint at what robust engagement can look like. But hope will not be enough if silence continues to dominate.
Medicine’s credibility depends on more than clinical expertise. It depends on the courage to speak when it matters most. Strategic silence may preserve political relationships, but it erodes the very foundation of medicine: the obligation to advocate for patients. In an era of political polarization and scientific skepticism, visible advocacy for evidence-based practice is not partisan. It is professional. It is ethical. And it is imperative.
Marilyn Uzdavines is a law professor. Vijay Rajput is an internal medicine physician.
